Phase II study of ifosfamide (Holoxan) in hepatoma.
Thongprasert
S
S
Department of Internal Medicine, Chiang Mai University, Thailand.
Klunklin
K
K
Phornphutkul
K
K
Prisontarangkul
O A
OA
Chaimongkol
B
B
Sivasomboon
B
B
D000328:Adult; D006528:Carcinoma, Hepatocellular / Q000188:drug therapy*; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D007069:Ifosfamide / Q000627:therapeutic use*; D007958:Leukocyte Count; D008113:Liver Neoplasms / Q000188:drug therapy* / Q000401:mortality; D008297:Male; D008875:Middle Aged; D010976:Platelet Count
D007069:Ifosfamide